{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:23:57Z","timestamp":1787235837102,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10072-023-06611-4","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:02:52Z","timestamp":1673866972000},"page":"1731-1737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-5726","authenticated-orcid":false,"given":"Edgar","family":"Carnero Contentti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo A.","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Pettinicchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Daccach Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibis Soto","family":"de Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Patrucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Caride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"issue":"7","key":"6611_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF (2022) Neuromyelitis optica spectrum disorder. N Engl J Med 387(7):631\u2013639","journal-title":"N Engl J Med"},{"issue":"1","key":"6611_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","volume":"18","author":"E Carnero Contentti","year":"2021","unstructured":"Carnero Contentti E, Correale J (2021) Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies. J Neuroinflammation 18(1):208","journal-title":"J Neuroinflammation"},{"issue":"2","key":"6611_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp-2016-313300","volume":"88","author":"I Kawachi","year":"2017","unstructured":"Kawachi I, Lassmann H (2017) Neurodegeneration in multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 88(2):137\u2013145","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"6611_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG (2015) International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177\u2013189","journal-title":"Neurology"},{"issue":"9451","key":"6611_CR5","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364(9451):2106\u20132112","journal-title":"Lancet"},{"issue":"1","key":"6611_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/1352458511431077","volume":"18","author":"DM Wingerchuk","year":"2012","unstructured":"Wingerchuk DM, Weinshenker BG (2012) The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 18(1):5\u201310","journal-title":"Mult Scler"},{"issue":"3","key":"6611_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3109\/08916934.2014.883501","volume":"47","author":"A Iyer","year":"2014","unstructured":"Iyer A, Elsone L, Appleton R, Jacob A (2014) A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Autoimmunity 47(3):154\u2013161","journal-title":"Autoimmunity"},{"key":"6611_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1001\/archneurol.2007.17","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA, de Seze J et al (2008) Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 65:78\u201383","journal-title":"Arch Neurol"},{"issue":"20","key":"6611_CR9","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","volume":"78","author":"MI Leite","year":"2012","unstructured":"Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C et al (2012) Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78(20):1601\u20131607","journal-title":"Neurology"},{"issue":"19","key":"6611_CR10","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1073\/pnas.0508716103","volume":"103","author":"G Bedoya","year":"2006","unstructured":"Bedoya G, Montoya P, Garc\u00eda J, Soto I, Bourgeois S, Carvajal L, Labuda D, Alvarez V, Ospina J, Hedrick PW, Ruiz-Linares A (2006) Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate. Proc Natl Acad Sci U S A 103(19):7234\u20137239","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"6611_CR11","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"3","key":"6611_CR12","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","volume":"2","author":"P Waters","year":"2015","unstructured":"Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, Jury\u0144czyk M, Tackley G, Rocha J, Takahashi T, Misu T, Nakashima I, Palace J, Fujihara K, Leite MI, Vincent A (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2(3):e89","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"8","key":"6611_CR13","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1136\/annrheumdis-2019-216222","volume":"80","author":"F Assan","year":"2021","unstructured":"Assan F, Seror R, Mariette X, Nocturne G (2021) New 2019 SLE EULAR\/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS. Ann Rheum Dis 80(8):e122. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216222 Epub 2019 Sep 9","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6611_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Sj\u00f6gren\u2019s International Collaborative Clinical Alliance (SICCA) Research Groups, Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schi\u00f8dt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64(4):475\u2013487","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"6611_CR15","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6611_CR16","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jama.1990.03440110095035","volume":"263","author":"MI Surks","year":"1990","unstructured":"Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH (1990) American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA. 263(11):1529\u20131532","journal-title":"JAMA."},{"issue":"11","key":"6611_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","volume":"84","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, Klawiter EC, Sato DK, de Seze J, Wuerfel J, Banwell BL, Villoslada P, Saiz A, Fujihara K, Kim SH (2015) Guthy-Jackson Charitable Foundation NMO International Clinical Consortium & Biorepository. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165\u20131173","journal-title":"Neurology"},{"key":"6611_CR18","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.msard.2020.102428","volume":"45","author":"E Carnero Contentti","year":"2020","unstructured":"Carnero Contentti E, Rojas JI, Cristiano E, Marques VD, Flores-Rivera J, Lana-Peixoto M, Navas C, Papais-Alvarenga R, Sato DK, Soto de Castillo I, Correale J (2020) Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice. Mult Scler Relat Disord 45:102428. https:\/\/doi.org\/10.1016\/j.msard.2020.102428 Epub 2020 Jul 29. Erratum in: Mult Scler Relat Disord. 2021 Jul;52:103026","journal-title":"Mult Scler Relat Disord"},{"issue":"13","key":"6611_CR19","doi-asserted-by":"publisher","first-page":"969762","DOI":"10.3389\/fneur.2022.969762","volume":"25","author":"Y Yao","year":"2022","unstructured":"Yao Y, Yang X, Zhou Y, Xie H, Duan R, Jing L, Li Y, Guan W, Teng J, Jia Y (2022) Comparative analysis of clinical and imaging data of first-attack neuromyelitis optica spectrum disorders with and without connective tissue disease. Front Neurol 25(13):969762. https:\/\/doi.org\/10.3389\/fneur.2022.969762","journal-title":"Front Neurol"},{"issue":"1","key":"6611_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12883-018-1182-5","volume":"18","author":"CS Yang","year":"2018","unstructured":"Yang CS, Zhang QX, Chang SH, Zhang LJ, Li LM, Qi Y, Wang J, Sun ZH, Zhangning N, Yang L, Shi FD (2018) Neuromyelitis optica spectrum disorders with and without connective tissue disorders. BMC Neurol 18(1):177. https:\/\/doi.org\/10.1186\/s12883-018-1182-5","journal-title":"BMC Neurol"},{"issue":"14","key":"6611_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12883-014-0162-7","volume":"19","author":"B Zhang","year":"2014","unstructured":"Zhang B, Zhong Y, Wang Y, Dai Y, Qiu W, Zhang L, Li H, Lu Z (2014) Neuromyelitis optica spectrum disorders without and with autoimmune diseases. BMC Neurol. 19(14):162. https:\/\/doi.org\/10.1186\/s12883-014-0162-7","journal-title":"BMC Neurol."},{"issue":"3","key":"6611_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1017\/neu.2016.49","volume":"29","author":"WLCJ Pereira","year":"2017","unstructured":"Pereira WLCJ, Reiche EMV, Kallaur AP, Oliveira SR, Sim\u00e3o ANC, Lozovoy MAB, Schiav\u00e3o LJV, Rodrigues PRDVP, Alfieri DF, Flauzino T, Kaimen-Maciel DR (2017) Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica. Acta Neuropsychiatr 29(3):170\u2013178. https:\/\/doi.org\/10.1017\/neu.2016.49 Epub 2016 Oct 3","journal-title":"Acta Neuropsychiatr"},{"issue":"2","key":"6611_CR23","doi-asserted-by":"publisher","first-page":"205521732110068","DOI":"10.1177\/20552173211006862","volume":"7","author":"S Asseyer","year":"2021","unstructured":"Asseyer S, Masuda H, Mori M, Bellmann-Strobl J, Ruprecht K, Siebert N, Cooper G, Chien C, Duchow A, Schlie\u00dfeit J, Liu J, Sugimoto K, Uzawa A, Ohtani R, Paul F, Brandt AU, Kuwabara S, Zimmermann HG (2021) AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Mult Scler J Exp Transl Clin 7(2):20552173211006862. https:\/\/doi.org\/10.1177\/20552173211006862","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"1","key":"6611_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13760-019-01176-6","volume":"120","author":"T Gkaniatsou","year":"2020","unstructured":"Gkaniatsou T, Papadopoulou A, Paul F, Brandt AU, Oertel FC (2020) Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders. Acta Neurol Belg. 120(1):223\u2013225. https:\/\/doi.org\/10.1007\/s13760-019-01176-6 Epub 2019 Jul 1","journal-title":"Acta Neurol Belg."},{"issue":"4","key":"6611_CR25","first-page":"298","volume":"69","author":"MP Mohan","year":"2003","unstructured":"Mohan MP, Ramesh TC (2003) Multiple autoimmune syndrome. Indian J Dermatol Venereol Leprol 69(4):298\u2013299","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"6611_CR26","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1212\/wnl.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53(5):1107\u20131114. https:\/\/doi.org\/10.1212\/wnl.53.5.1107","journal-title":"Neurology"},{"key":"6611_CR27","doi-asserted-by":"publisher","first-page":"Doc22","DOI":"10.3205\/000226","volume":"13","author":"SR Sudulagunta","year":"2015","unstructured":"Sudulagunta SR, Sodalagunta MB, Khorram H, Sepehrar M, Gonivada J, Noroozpour Z, Prasad N (2015) Autoimmune thyroiditis associated with neuromyelitis optica (NMO). Ger Med Sci 13:Doc22. https:\/\/doi.org\/10.3205\/000226","journal-title":"Ger Med Sci"},{"issue":"11","key":"6611_CR28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10067-010-1502-7","volume":"29","author":"P Sergio","year":"2010","unstructured":"Sergio P, Mariana B, Alberto O, Claudia U, Oscar R, Pablo M, Alberto A (2010) Association of neuromyelitis optic (NMO) with autoimmune disorders: report of two cases and review of the literature. Clin Rheumatol. 29(11):1335\u20131338. https:\/\/doi.org\/10.1007\/s10067-010-1502-7 Epub 2010 Jun 11","journal-title":"Clin Rheumatol."},{"issue":"3","key":"6611_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000448286","volume":"23","author":"C Chen","year":"2016","unstructured":"Chen C, Xiaobo S, Yuge W, Yaqing S, Ling F, Lisheng P, Zhengqi L, Wei Q (2016) Multiple Autoantibodies and Neuromyelitis Optica Spectrum Disorders. Neuroimmunomodulation 23(3):151\u2013156. https:\/\/doi.org\/10.1159\/000448286 Epub 2016 Sep 8","journal-title":"Neuroimmunomodulation"},{"key":"6611_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","volume":"27","author":"S Shahmohammadi","year":"2019","unstructured":"Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, Harirchian MH, Asgari N, Naser MA (2019) Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: a literature review. Mult Scler Relat Disord 27:350\u2013363. https:\/\/doi.org\/10.1016\/j.msard.2018.11.008 Epub 2018 Nov 16","journal-title":"Mult Scler Relat Disord"},{"key":"6611_CR31","unstructured":"Rodriguez Alvarez M, Zhaz Leon S, Cuascut F, Kabani N, Pathiparampil J, Koci K, Bhamra M, Freeman L, Kreps A, Levinson J, Francis S, Velayndhan V, Xie S, Amarnani A, Valsamis H, Anziska Y, Ginzler EM, McFarlane IM (2018) Rheumatic Diseases Associated with Neuromyelitis Optica Spectrum Disorders (NMOSD): Prevalence, Clinical, Laboratory and Imaging Characteristics [abstract]. Arthritis. Rheumatol 70(suppl 10) https:\/\/acrabstracts.org\/abstract\/rheumatic-diseases-associated-with-neuromyelitis-optica-spectrum-disorders-nmosd-prevalence-clinical-laboratory-and-imaging-characteristics\/. Accessed September 23, 2022"},{"issue":"1","key":"6611_CR32","doi-asserted-by":"publisher","first-page":"e01865","DOI":"10.1002\/brb3.1865","volume":"11","author":"R Fan","year":"2021","unstructured":"Fan R, Zhang Y, Xu Y, Tong J, Chen Z, Gu M, Fan W, Chen Y, Peng F, Jiang Y (2021) Serum antinuclear antibodies associate with worse prognosis in AQP4-positive neuromyelitis optica spectrum disorder. Brain Behav 11(1):e01865. https:\/\/doi.org\/10.1002\/brb3.1865","journal-title":"Brain Behav"},{"issue":"9","key":"6611_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/1352458511403958","volume":"17","author":"S Jarius","year":"2011","unstructured":"Jarius S, Jacobi C, de Seze J, Zephir H, Paul F, Franciotta D, Rommer P, Mader S, Kleiter I, Reindl M, Akman-Demir G, Seifert-Held T, Kristoferitsch W, Melms A, Wandinger KP, Wildemann B (2011) Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler 17(9):1067\u20131073. https:\/\/doi.org\/10.1177\/1352458511403958 Epub 2011 May 4","journal-title":"Mult Scler"},{"issue":"5","key":"6611_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1007\/s10165-011-0572-y","volume":"22","author":"Y Katsumata","year":"2012","unstructured":"Katsumata Y, Kawachi I, Kawaguchi Y, Gono T, Ichida H, Hara M, Yamanaka H (2012) Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases. Mod Rheumatol 22(5):676\u2013684. https:\/\/doi.org\/10.1007\/s10165-011-0572-y Epub 2011 Dec 20","journal-title":"Mod Rheumatol"},{"issue":"11","key":"6611_CR35","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1177\/0961203319877255","volume":"28","author":"E Mart\u00edn-Nares","year":"2019","unstructured":"Mart\u00edn-Nares E, Hernandez-Molina G, Fragoso-Loyo H (2019) Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience. Lupus. 28(11):1302\u20131311. https:\/\/doi.org\/10.1177\/0961203319877255 Epub 2019 Sep 29","journal-title":"Lupus."},{"issue":"28","key":"6611_CR36","doi-asserted-by":"publisher","first-page":"e1145","DOI":"10.1097\/MD.0000000000001145","volume":"94","author":"L Qiao","year":"2015","unstructured":"Qiao L, Wang Q, Fei Y, Zhang W, Xu Y, Zhang Y, Zhao Y, Zeng X, Zhang F (2015) The Clinical Characteristics of Primary Sjogren\u2019s Syndrome With Neuromyelitis Optica Spectrum Disorder in China: a STROBE-Compliant Article. Medicine (Baltimore). 94(28):e1145. https:\/\/doi.org\/10.1097\/MD.0000000000001145","journal-title":"Medicine (Baltimore)."},{"key":"6611_CR37","doi-asserted-by":"publisher","first-page":"103494","DOI":"10.1016\/j.msard.2022.103494","volume":"58","author":"L Lin","year":"2022","unstructured":"Lin L, Hang H, Zhang J, Lu J, Chen D, Shi J (2022) Clinical significance of anti-SSA\/Ro antibody in Neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 58:103494. https:\/\/doi.org\/10.1016\/j.msard.2022.103494 Epub 2022 Jan 10","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"6611_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1177\/1352458508088941","volume":"14","author":"A Javed","year":"2008","unstructured":"Javed A, Balabanov R, Arnason BG, Kelly TJ, Sweiss NJ, Pytel P, Walsh R, Blair EA, Stemer A, Lazzaro M, Reder AT (2008) Minor salivary gland inflammation in Devic's disease and longitudinally extensive myelitis. Mult Scler. 14(6):809\u2013814. https:\/\/doi.org\/10.1177\/1352458508088941 Epub 2008 Jun 23","journal-title":"Mult Scler."},{"issue":"8","key":"6611_CR39","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.bbamem.2006.01.022","volume":"1758","author":"C Delporte","year":"2006","unstructured":"Delporte C, Steinfeld S (2006) Distribution and roles of aquaporins in salivary glands. Biochim Biophys Acta 1758(8):1061\u20131070. https:\/\/doi.org\/10.1016\/j.bbamem.2006.01.022 Epub 2006 Feb 28","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"6611_CR40","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3174\/ajnr.A3756","volume":"35","author":"LC Tzarouchi","year":"2014","unstructured":"Tzarouchi LC, Zikou AK, Tsifetaki N, Astrakas LG, Konitsiotis S, Voulgari P, Drosos A, Argyropoulou MI (2014) White matter water diffusion changes in primary Sj\u00f6gren syndrome. AJNR Am J Neuroradiol 35(4):680\u2013685. https:\/\/doi.org\/10.3174\/ajnr.A3756","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"6611_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11926-021-01000-2","volume":"23","author":"RA Cruz","year":"2021","unstructured":"Cruz RA, Chaudhary S, Guevara M, Meltzer E (2021) Neuromyelitis optica spectrum disorders (NMOSD) and connective tissue disease (CTD): an update for the rheumatologist. Curr Rheumatol Rep. 23(6):33. https:\/\/doi.org\/10.1007\/s11926-021-01000-2","journal-title":"Curr Rheumatol Rep."},{"issue":"4","key":"6611_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.18773\/austprescr.2016.053","volume":"39","author":"KL Randall","year":"2016","unstructured":"Randall KL (2016) Rituximab in autoimmune diseases. Aust Prescr. 39(4):131\u2013134. https:\/\/doi.org\/10.18773\/austprescr.2016.053","journal-title":"Aust Prescr."},{"issue":"4","key":"6611_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1474-4422(20)30066-1","volume":"19","author":"M Tahara","year":"2020","unstructured":"Tahara M, Oeda T, Okada K et al (2020) Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 19(4):298\u2013306","journal-title":"Lancet Neurol"},{"issue":"7","key":"6611_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ncprheum0818","volume":"4","author":"J Birnbaum","year":"2008","unstructured":"Birnbaum J, Kerr D (2008) Optic neuritis and recurrent myelitis in a woman with systemic lupus erythematosus. Nat Clin Pract Rheumatol 4(7):381\u2013386. https:\/\/doi.org\/10.1038\/ncprheum0818 Epub 2008 May 20","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"383","key":"6611_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jns.2017.10.036","volume":"15","author":"AB Ramos","year":"2017","unstructured":"Ramos AB, Peters CW, Landry-Wegener B, Cannizzaro LA, Lovera J (2017) A case of neuromyelitis optica spectrum disorder presenting with undiagnosed Sjogren's syndrome and a single, atypical tumefactive lesion: a clinical conundrum. J Neurol Sci 15(383):216\u2013218. https:\/\/doi.org\/10.1016\/j.jns.2017.10.036 Epub 2017 Nov 7","journal-title":"J Neurol Sci"},{"issue":"5","key":"6611_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.26442\/terarkh201890576-80","volume":"90","author":"AV Torgashina","year":"2018","unstructured":"Torgashina AV, Vasilyev VI (2018) The efficacy of rituximab in the therapy of neuromyelitis optica in a patient with Sjogren\u2019s syndrome: case-report and literature review. Ter Arkh. 90(5):76\u201380. https:\/\/doi.org\/10.26442\/terarkh201890576-80","journal-title":"Ter Arkh."}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06611-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06611-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T20:06:12Z","timestamp":1681416372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06611-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6611"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06611-4","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of each participating center","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"A written or verbal informed consent for the use of the anonymized data for research objectives was obtained from all participants before data collection.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}